Jacksonville South: 904-281-5757 | Jacksonville UNC: 904-281-5757 | Memphis: 901-843-1045 | Orlando Downtown: 407-425-5100 |
Orlando SODO: 407-722-5313
Jacksonville: 904-281-5757 | Memphis: 901-843-1045
Downtown Orlando: 407-425-5100 | Orlando SODO: 407-425-5100
Cytomegalovirus (CMV) is a leading cause of birth defects around the world, and it is a common viral infection that usually goes unnoticed or only causes mild symptoms in most people. But if a woman becomes infected with the virus while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases. Currently, there is no approved vaccine against the virus.
CMV vaccine clinical trials, like those at CNS Healthcare, can help you explore new options to protect yourself against this virus. Interested in trying a new vaccine treatment at no cost? Find out more about enrolling vaccine clinical trials available by selecting one of the below locations near you. Use the form on the page to schedule a free, in-office consultation to find out if a vaccine clinical trial is right for you.
People with the virus may pass it in bodily fluids, such as saliva, urine, blood, tears, semen, and breast milk. The virus is spread from an infected person in the following ways:
Over half of adults have been infected with the virus by age 40. Once the virus is in a person’s body, it stays there for life and can reactivate. Most people infected with the virus show no signs or symptoms. In some cases, infection in healthy people can cause mild illness that may include:
People with weakened immune systems who get CMV can have more serious symptoms affecting the eyes, lungs, liver, esophagus, stomach, and intestines.
Babies born with the virus can have brain, liver, spleen, lung, and growth problems. The most common long-term health problem in babies born with congenital CMV infection is hearing loss, which may be detected soon after birth or may develop later in childhood.
Since opening our doors in 1996, CNS Healthcare has had the privilege of assisting in the development of some of the most widely prescribed medicines in the world. We continue to lead the way in providing the clinical research necessary to identify medications for the FDA to review and, once approved, physicians to prescribe. CNS has conducted thousands of clinical trials, improved millions of lives, and is proud to have helped in the FDA approval of nearly 100 new treatments.
